Overview
A depressor amine derived by enzymatic decarboxylation of histidine. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter.
Indication
Histamine phosphate is indicated as a diagnostic aid for the evaluation of gastric acid secretory function.
Associated Conditions
- Migraine
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2023/04/12 | Phase 2 | Not yet recruiting | Sahlgrenska University Hospital, Sweden | ||
2021/01/07 | Not Applicable | Completed | Aalborg University | ||
2020/12/21 | Not Applicable | Completed | |||
2020/10/19 | Not Applicable | Completed | Aalborg University | ||
2020/09/18 | Not Applicable | Completed | Aalborg University | ||
2019/10/04 | Not Applicable | Completed | Aalborg University | ||
2019/08/15 | Not Applicable | Completed | |||
2016/09/05 | Phase 1 | Completed | |||
2013/10/16 | Not Applicable | Completed | Guangzhou Institute of Respiratory Disease | ||
2012/11/01 | Phase 1 | Completed | Anergis |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| King Bio Inc. | 57955-9003 | ORAL | 10 [hp_X] in 59 mL | 5/19/2025 | |
| Deseret Biologicals, Inc. | 43742-2218 | ORAL | 6 [hp_X] in 1 mL | 5/27/2025 | |
| Nutritional Specialties, Inc. | 83027-0123 | ORAL | 12 [hp_X] in 1 mL | 5/15/2025 | |
| Boiron | 0220-9303 | ORAL | 9 [hp_C] in 1 1 | 5/12/2025 | |
| SEVENE USA | 76472-5003 | SUBLINGUAL | 30 [hp_C] in 1 1 | 5/15/2025 | |
| ALK-Abello, Inc. | 0268-0247 | PERCUTANEOUS | 2.75 mg in 1 mL | 8/25/2020 | |
| Jubilant HollisterStier LLC | 65044-9998 | PERCUTANEOUS | 6 mg in 1 mL | 11/1/2023 | |
| Home Aide Diagnostics, Inc. | 69379-001 | TOPICAL | 0.035 g in 100 g | 7/8/2015 | |
| Eight and Company L.L.C | 61096-2004 | ORAL | 200 [hp_C] in 1 mL | 5/15/2025 | |
| King Bio Inc. | 57955-0762 | ORAL | 12 [hp_X] in 59 mL | 5/20/2025 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
Authorised | 10/7/2008 |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| Biochemics Hayfever | 120022 | Medicine | A | 6/22/2005 | |
| Allergy Oral Spray | 351127 | Medicine | A | 12/8/2020 | |
| Snoreeze Oral Spray | 351124 | Medicine | A | 12/8/2020 |
Help Us Improve
Your feedback helps us provide better drug information and insights.